[1]
Khan, S. et al. 2023. Response of Tocilizumab in Treating Severe to Critical COVID-19; Single-Centre Experience at a Tertiary Care Centre. Pakistan Armed Forces Medical Journal. 73, 5 (Oct. 2023), 1468–1471. DOI:https://doi.org/10.51253/pafmj.v73i5.7532.